红花注射液联合低分子肝素治疗不稳定型心绞痛58例疗效分析

The efficacy of safflower injection combined with low molecular weight heparin for un- stable angina in 58 patients

目的探讨分析红花注射液联合低分子肝素治疗不稳定型心绞痛的临床治疗效果。方法选取2008年3月至2011年8月来我院就诊治疗的58例不稳定型心绞痛患者，随机分为对照组和治疗组，对照组29例患者采用常规治疗，治疗组29例患者在常规治疗的基础上加以红花注射液配合低分子肝素的联合治疗，比较两组患者治疗后的疗效和血液流变学变化差异。结果治疗组总治疗有效率为89．7％，高于对照组的62．1％；而且治疗组血液流变学改善明显优于对照组，P〈0．05。结论红花注射液联合低分子肝素治疗不稳定型心绞痛具有较为显著的临床疗效，而且能明显改善患者的血液流变学，值得临床推广应用。

Objective To investigate the clinical efficacy of safflower injection combined with low molecular weight heparin for unstable angina, Methods 58 patients with unstable angina who had visited our hospital during the period of March 2008 to August 2011 were randomly divided into a control group and a study group, The control group （ 29 patients ） received conventional treatment while the study group received combination therapy with safflower injections and low molecular weight heparin in addition to the conventional treatment, The efficacy, and changes in blood flow were compared between the two groups after treatment. Results The overall effectiveness rate was higher in the study group than in the control group （~ 89.7% vs. 62.1% 1 the study group was superior to the control in the improvement in blood flow （ P 〈 0.05 ）. Conclusions Safflower injection combined with low molecular weight heparin has a marked clinical efficacy in the treatment of unstable angina and has a significant effect on hemorheology in patients. It is worth popularizing clinically,